ATHE — Alterity Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $71.13m
- $49.70m
- AU$0.45m
- 39
- 14
- 92
- 46
Annual cashflow statement for Alterity Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.392 | 4.58 | 0.016 | 8.85 | 6.08 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.3 | -12.3 | -20 | -12.6 | -11.5 |
| Capital Expenditures | -0.01 | -0.089 | -0.007 | -0.006 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.029 | 0 | -7.5 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.01 | -0.089 | -0.036 | -0.006 | -7.5 |
| Financing Cash Flow Items | -2.49 | -0.837 | -0.132 | -0.918 | -2.77 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.7 | 16.3 | 0.124 | 9.22 | 39.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.9 | 6.69 | -19 | -3.13 | 20.5 |